XML 79 R62.htm IDEA: XBRL DOCUMENT v3.6.0.2
Quarterly Results of Operations (Unaudited) (Tables)
 12 Months Ended
Dec. 31, 2016
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Results of Operations (Unaudited)
 
Quarters Ended
 
December 31,
2016
 
September 30,
2016
 
June 30,
2016
 
March 31,
2016
Revenue
$
323,904

 
$
359,448

 
$
373,054

 
$
330,757

Expenses
237,901

 
271,678

 
385,018

 
328,657

Other income (expense), net
(96,205
)
 
(85,406
)
 
(84,434
)
 
(104,225
)
Income (loss) before income taxes
(10,202
)
 
2,364

 
(96,398
)
 
(102,125
)
Income tax expense (benefit)
228

 
(7,110
)
 
(9,180
)
 
9,076

Net income (loss)
(10,430
)
 
9,474

 
(87,218
)
 
(111,201
)
Net income attributable to non-controlling interests
(14
)
 
(83
)
 
(160
)
 
(130
)
Net income (loss) attributable to Ocwen common stockholders
$
(10,444
)
 
$
9,391

 
$
(87,378
)
 
$
(111,331
)
 
 
 
 
 
 
 
 
Earnings (loss) per share attributable to Ocwen common stockholders
 
 
 
 
 
 
 
Basic
$
(0.08
)
 
$
0.08

 
$
(0.71
)
 
$
(0.90
)
Diluted
$
(0.08
)
 
$
0.08

 
$
(0.71
)
 
$
(0.90
)

 
Quarters Ended
 
December 31,
2015
 
September 30,
2015
 
June 30,
2015
 
March 31,
2015
Revenue
$
362,457

 
$
404,946

 
$
463,251

 
$
510,444

Expenses
359,848

 
387,726

 
352,252

 
378,358

Other income (expense), net (1)
(131,881
)
 
(73,138
)
 
(98,499
)
 
(89,257
)
Income (loss) before income taxes
(129,272
)
 
(55,918
)
 
12,500

 
42,829

Income tax expense
94,985

 
10,832

 
2,594

 
8,440

Net income (loss)
(224,257
)
 
(66,750
)
 
9,906

 
34,389

Net loss (income) attributable to non-controlling interests
16

 
(119
)
 
(168
)
 
(34
)
Net income (loss) attributable to Ocwen common stockholders
$
(224,241
)
 
$
(66,869
)
 
$
9,738

 
$
34,355

 
 
 
 
 
 
 
 
Earnings (loss) per share attributable to Ocwen common stockholders
 
 
 
 
 
 
 
Basic
$
(1.79
)
 
$
(0.53
)
 
$
0.08

 
$
0.27

Diluted
$
(1.79
)
 
$
(0.53
)
 
$
0.08

 
$
0.27


(1)
Other income (expense), net for 2015 includes gains (losses) on the sale of MSRs in the first, second, third and fourth quarter of $26.4 million, $30.3 million, $41.2 million and $(14.0) million, respectively.